Product catalog antigen listed by alphabetic starting with F
| Items 1 to 100 of 881 total | 9 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| 10-288-21950F | F-actin capping protein alpha-1 subunit antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-21950F-50 | F-actin capping protein alpha-1 subunit antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00002159-P01-10 | F10 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002159-P01-25 | F10 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002160-Q01-10 | F11 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002160-Q01-25 | F11 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002161-Q01-10 | F12 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002161-Q01-25 | F12 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002162-P01-10 | F13A1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002162-P01-25 | F13A1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX26098 | F1A alpha peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00002147-Q01-10 | F2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002147-Q01-25 | F2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002150-Q01-10 | F2RL1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002150-Q01-25 | F2RL1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002152-Q01-10 | F3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002152-Q01-25 | F3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002153-Q01-10 | F5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002153-Q01-25 | F5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002155-Q01-10 | F7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002155-Q01-25 | F7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002157-Q01-10 | F8 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002157-Q01-25 | F8 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002158-Q01-10 | F9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002158-Q01-25 | F9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002166-Q01-10 | FAAH antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002166-Q01-25 | FAAH antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002168-P01-10 | FABP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002168-P01-25 | FABP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002170-P01-10 | FABP3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002170-P01-25 | FABP3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1290 | FABP3 antigen | ||||||
| Human | Purified | >90% | E. coli | 5 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1290X | FABP3 antigen | ||||||
| Human | Purified | >90% | E. coli | 20 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1290XC | FABP3 antigen | ||||||
| Human | Purified | >90% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| 8F65 | FABP3 antigen | ||||||
| Human | >98% | Cardiac muscle | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| H00002172-P01-02 | FABP6 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002172-P01-10 | FABP6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002172-P01-25 | FABP6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002173-P01-10 | FABP7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002173-P01-25 | FABP7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA205 | Factor H antigen | ||||||
| Human | >90% | Serum | 0.25 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| AR00049PU-N | Factor IX antigen | ||||||
| Mouse | Purified | Plasma | 50 µg / --- | ||||
| Acris Antibodies GmbH | |||||||
| PA1294 | Factor IX antigen | ||||||
| Human | Purified | >98% | Plasma | 100 U / US$ 375 | |||
| Acris Antibodies GmbH | |||||||
| PA1294X | Factor IX antigen | ||||||
| Human | Purified | >98% | Plasma | 500 U / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1294XC | Factor IX antigen | ||||||
| Human | Purified | >98% | Plasma | 1000 U / ask | |||
| Acris Antibodies GmbH | |||||||
| AR00050PU-N | Factor IX, Rat antigen | ||||||
| Rat | Purified | Plasma | 50 µg / --- | ||||
| Acris Antibodies GmbH | |||||||
| AR00051PU-N | Factor IXa, Rat antigen | ||||||
| Rat | Purified | Plasma | 50 µg / --- | ||||
| Acris Antibodies GmbH | |||||||
| PA1291 | Factor VIIa antigen | ||||||
| Human | Purified | >98% | BHK cells | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1291X | Factor VIIa antigen | ||||||
| Human | Purified | >98% | BHK cells | 50 µg / US$ 525 | |||
| Acris Antibodies GmbH | |||||||
| PA1291XC | Factor VIIa antigen | ||||||
| Human | Purified | >98% | BHK cells | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1292 | Factor VIII antigen | ||||||
| Human | Purified | >98% | Plasma | 400 U / US$ 515 | |||
| Acris Antibodies GmbH | |||||||
| PA1292X | Factor VIII antigen | ||||||
| Human | Purified | >98% | Plasma | 800 U / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1292XC | Factor VIII antigen | ||||||
| Human | Purified | >98% | Plasma | 1200 U / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1293 | Factor VIII antigen | ||||||
| Human | Purified | >98% | CHO cells | 250 U / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1293X | Factor VIII antigen | ||||||
| Human | Purified | >98% | CHO cells | 500 U / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1293XC | Factor VIII antigen | ||||||
| Human | Purified | >98% | CHO cells | 1000 U / ask | |||
| Acris Antibodies GmbH | |||||||
| BA1119 | Factor X antigen | ||||||
| Mouse | Purified | - | Plasma | 0.1 mg / --- | |||
| Acris Antibodies GmbH | |||||||
| BA1120 | Factor Xa antigen | ||||||
| Mouse | Purified | - | Plasma | 0.1 mg / --- | |||
| Acris Antibodies GmbH | |||||||
| AR00052PU-N | Factor XI antigen | ||||||
| Human | Purified | Plasma | 0.1 mg / --- | ||||
| Acris Antibodies GmbH | |||||||
| H00008772-Q01-10 | FADD antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008772-Q01-25 | FADD antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003992-P01-10 | FADS1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003992-P01-25 | FADS1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003992-Q01-10 | FADS1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003992-Q01-25 | FADS1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003995-Q01-10 | FADS3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003995-Q01-25 | FADS3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011124-Q01-10 | FAF1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011124-Q01-25 | FAF1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023017-P01-10 | FAIM2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023017-P01-25 | FAIM2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009214-Q01-10 | FAIM3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009214-Q01-25 | FAIM3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009780-P01-10 | FAM38A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009780-P01-25 | FAM38A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009130-P01-10 | FAM50A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009130-P01-25 | FAM50A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009130-Q01-10 | FAM50A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009130-Q01-25 | FAM50A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057488-P01-10 | FAM62B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057488-P01-25 | FAM62B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002175-P01-10 | FANCA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002175-P01-25 | FANCA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002176-Q01-10 | FANCC antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002176-Q01-25 | FANCC antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002189-P01-10 | FANCG / XRCC9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002189-P01-25 | FANCG / XRCC9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055120-P01-10 | FANCL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055120-P01-25 | FANCL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002191-Q01-10 | FAP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002191-Q01-25 | FAP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1227 | Farnesoid X-Activated Receptor (FXR/NR1H4) antigen | ||||||
| Rat | Purified | >90% | E. coli | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1227X | Farnesoid X-Activated Receptor (FXR/NR1H4) antigen | ||||||
| Rat | Purified | >90% | E. coli | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1227XC | Farnesoid X-Activated Receptor (FXR/NR1H4) antigen | ||||||
| Rat | Purified | >90% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| H00009855-Q01-10 | FARP2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009855-Q01-25 | FARP2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002193-Q01-10 | FARSLA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002193-Q01-25 | FARSLA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010056-P01-10 | FARSLB antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010056-P01-25 | FARSLB antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 1 to 100 of 881 total | 9 Page(s): |


